Bobby Quentin Lanier

Learn More
BACKGROUND Many children with asthma continue to experience symptoms despite available therapies. OBJECTIVE This study evaluated the efficacy and safety of omalizumab, a humanized anti-IgE mAb, in(More)
BACKGROUND Olopatadine hydrochloride 0.1% ophthalmic solution (Patanol) and epinastine hydrochloride 0.05% ophthalmic solution (Elestat) are two topical antiallergic agents. Olopatadine is indicated(More)